In this study, we determined the serum levels of the anti-GAPDH autoantibodies in SLE patients and healthy controls, and for the first time, we analyzed the clinical relevance of the serum anti-GAPDH levels with laboratory and clinical features of SLE patients. This evidence concerns the gene GAPDH and systemic lupus erythematosus.